New Key Statistics Module, Z-Score and F-Score
SZSE:002788 Key Ratios
Market Cap ¥ M | 3,011.01 |
Enterprise Value ¥ M | 7,590.22 |
P/E(ttm) | 8.24 |
PE Ratio without NRI | 8.24 |
Forward PE Ratio | -- |
Price/Book | 1.00 |
Price/Sales | 0.15 |
Price/Free Cash Flow | 5.24 |
Price/Owner Earnings | 33.26 |
Payout Ratio % | 0.32 |
Revenue (TTM) ¥ M | 20,139.00 |
EPS (TTM) ¥ | 0.94 |
Beneish M-Score | -2.64 |
10-y EBITDA Growth Rate % | 11.40 |
5-y EBITDA Growth Rate % | 11.30 |
y-y EBITDA Growth Rate % | 1.10 |
EV-to-EBIT | 10.90 |
EV-to-EBITDA | 10.90 |
PEG | 0.73 |
Shares Outstanding M | 388.52 |
Net Margin (%) | 1.82 |
Operating Margin % | 3.58 |
Pre-tax Margin (%) | 2.35 |
Quick Ratio | 0.85 |
Current Ratio | 1.16 |
ROA % (ttm) | 3.16 |
ROE % (ttm) | 12.75 |
ROIC % (ttm) | 7.32 |
Dividend Yield % | 3.87 |
Altman Z-Score | 2.41 |
SZSE:002788 Number of Guru Trades
SZSE:002788 Volume of Guru Trades
Gurus Latest Trades with SZSE:002788
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002788 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Luyan Pharma Co Ltd Insider Transactions
No Available Data